We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Novo Nordisk A/S (NVO) - free report >>
Alaska Air Group, Inc. (ALK) - free report >>
Theravance Biopharma, Inc. (TBPH) - free report >>
Image: Shutterstock
New Strong Buy Stocks for February 14th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Inspire Medical Systems, Inc. (INSP - Free Report) : This medical technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 40.6% over the last 60 days.
Inspire Medical Systems, Inc. Price and Consensus
Inspire Medical Systems, Inc. price-consensus-chart | Inspire Medical Systems, Inc. Quote
Alaska Air Group, Inc. (ALK - Free Report) : This airline company has seen the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
Alaska Air Group, Inc. Price and Consensus
Alaska Air Group, Inc. price-consensus-chart | Alaska Air Group, Inc. Quote
STRATA Skin Sciences, Inc. (SSKN - Free Report) : This dermatology-focused medical technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 5% over the last 60 days.
Strata Skin Sciences, Inc. Price and Consensus
Strata Skin Sciences, Inc. price-consensus-chart | Strata Skin Sciences, Inc. Quote
Novo Nordisk A/S (NVO - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.
Novo Nordisk A/S Price and Consensus
Novo Nordisk A/S price-consensus-chart | Novo Nordisk A/S Quote
Theravance Biopharma, Inc. (TBPH - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.
Theravance Biopharma, Inc. Price and Consensus
Theravance Biopharma, Inc. price-consensus-chart | Theravance Biopharma, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.